Vir Biotechnology, Inc. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2020-05-08: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2020-05-06; Total offering amount $32,444,441.
- 2020-05-08: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2020-04-29; Total offering amount $250,000,000.
- 2018-06-29: Federal exemption Rule 506(c); Types of securities offered Equity; Date of first sale 2018-06-14; Total offering amount Indefinite.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|
| 2020-05-08 | Rule 506(b) | Equity | 2020-05-06 | $32,444,441 | $32,444,441 | $0 | 1 |
|---|
| 2020-05-08 | Rule 506(b) | Equity | 2020-04-29 | $250,000,000 | $250,000,000 | $0 | 1 |
|---|
| 2018-06-29 | Rule 506(c) | Equity | 2018-06-14 | Indefinite | $66,000,000 | Indefinite | 5 |
|---|